Based on a study elucidating the tumor biology of increasing SUV such as MYC-overexpression (Palaskas et al. 2011) or centromere protein F-expression, breast cancer with high SUV levels could indicate aggressive tumors. This evidence concerns the gene CENPF and neoplasm.